Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 2
1973 1
1975 2
1979 1
1980 1
1981 1
1982 2
1983 1
1984 5
1985 5
1986 4
1987 1
1988 2
1990 1
1992 2
1994 6
1995 9
1996 9
1997 8
1998 12
1999 4
2000 4
2001 14
2002 11
2003 7
2004 10
2005 6
2006 5
2007 10
2008 7
2009 6
2010 22
2011 32
2012 38
2013 29
2014 22
2015 19
2016 26
2017 24
2018 24
2019 24
2020 24
2021 25
2022 20
2023 23
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

459 results

Results by year

Filters applied: . Clear all
Page 1
Medikamenten-induzierte intertriginöse amikrobielle Pustulose.
Inamura E, Yamaguchi Y, Fujimura Y, Haga N, Iwata H. Inamura E, et al. Among authors: haga n. J Dtsch Dermatol Ges. 2021 Mar;19(3):430-433. doi: 10.1111/ddg.14361_g. J Dtsch Dermatol Ges. 2021. PMID: 33709578 German. No abstract available.
Reduction of New Heterotopic Ossification (HO) in the Open-Label, Phase 3 MOVE Trial of Palovarotene for Fibrodysplasia Ossificans Progressiva (FOP).
Pignolo RJ, Hsiao EC, Al Mukaddam M, Baujat G, Berglund SK, Brown MA, Cheung AM, De Cunto C, Delai P, Haga N, Kannu P, Keen R, Le Quan Sang KH, Mancilla EE, Marino R, Strahs A, Kaplan FS. Pignolo RJ, et al. Among authors: haga n. J Bone Miner Res. 2023 Mar;38(3):381-394. doi: 10.1002/jbmr.4762. Epub 2023 Jan 25. J Bone Miner Res. 2023. PMID: 36583535 Free article.
Gene Therapy for Fibrodysplasia Ossificans Progressiva: Feasibility and Obstacles.
Eekhoff EMW, de Ruiter RD, Smilde BJ, Schoenmaker T, de Vries TJ, Netelenbos C, Hsiao EC, Scott C, Haga N, Grunwald Z, De Cunto CL, di Rocco M, Delai PLR, Diecidue RJ, Madhuri V, Cho TJ, Morhart R, Friedman CS, Zasloff M, Pals G, Shim JH, Gao G, Kaplan F, Pignolo RJ, Micha D. Eekhoff EMW, et al. Among authors: haga n. Hum Gene Ther. 2022 Aug;33(15-16):782-788. doi: 10.1089/hum.2022.023. Hum Gene Ther. 2022. PMID: 35502479 Free PMC article. Review.
Interleukin-6 induces drug resistance in renal cell carcinoma.
Ishibashi K, Koguchi T, Matsuoka K, Onagi A, Tanji R, Takinami-Honda R, Hoshi S, Onoda M, Kurimura Y, Hata J, Sato Y, Kataoka M, Ogawsa S, Haga N, Kojima Y. Ishibashi K, et al. Among authors: haga n. Fukushima J Med Sci. 2018 Dec 8;64(3):103-110. doi: 10.5387/fms.2018-15. Epub 2018 Oct 23. Fukushima J Med Sci. 2018. PMID: 30369518 Free PMC article. Review.
Special considerations for clinical trials in fibrodysplasia ossificans progressiva (FOP).
Hsiao EC, Di Rocco M, Cali A, Zasloff M, Al Mukaddam M, Pignolo RJ, Grunwald Z, Netelenbos C, Keen R, Baujat G, Brown MA, Cho TJ, De Cunto C, Delai P, Haga N, Morhart R, Scott C, Zhang K, Diecidue RJ, Friedman CS, Kaplan FS, Eekhoff EMW. Hsiao EC, et al. Among authors: haga n. Br J Clin Pharmacol. 2019 Jun;85(6):1199-1207. doi: 10.1111/bcp.13777. Epub 2018 Nov 6. Br J Clin Pharmacol. 2019. PMID: 30281842 Free PMC article. Review.
Effect of Pharmacotherapy for Overactive Bladder on the Incidence of and Factors Related to Urinary Tract Infection: A Systematic Review and Meta-analysis.
Tsubouchi K, Arima H, Abe M, Matsuzaki H, Tominaga K, Fujikawa A, Gunge N, Miyazaki T, Okabe Y, Nakamura N, Matsuoka H, Okutsu S, Tada K, Haga N. Tsubouchi K, et al. Among authors: haga n. J Urol. 2023 Apr;209(4):665-674. doi: 10.1097/JU.0000000000003209. Epub 2023 Feb 14. J Urol. 2023. PMID: 36787147 Review.
459 results